Symptoms include intellectual disability, epilepsy, insomnia, and brain MRI abnormalities, and rodent models of Galnt2 knockout also displayed neurologic abnormalities consistent with a functional role of Galnt2-mediated glycosylation in the brain. The gene discussed is GALNT2; the disease is insomnia.